drugset / Trial / NCT07088328

Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial

NCT07088328

Not yet recruiting 30 enrolled Alexandria University
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to determine the value of Pentoxifylline for nephroprotection in these neonates with perinatal asphyxia, using cystatin C, regional oxygenation measured near infrared spectroscopy and renal Doppler sonography.

Timeline

Start
2025-07-30
Primary completion
2026-01-30
Completion
2026-03-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentoxifylline Small molecule 5 mg/kg Intravenous